🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 9 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/03/2019 | 77,37 | 78,53 | 76,09 | 77,17 | -0,26% | 3,14% | 787.394 |
| 19/03/2019 | 78,35 | 78,35 | 76,27 | 77,37 | -0,49% | 2,65% | 1.024.798 |
| 18/03/2019 | 74,85 | 78,54 | 74,17 | 77,75 | +4,70% | 5,83% | 1.346.680 |
| 15/03/2019 | 73,65 | 74,42 | 72,16 | 74,25 | +0,70% | 3,07% | 2.362.982 |
| 14/03/2019 | 72,56 | 74,60 | 72,56 | 73,74 | +1,62% | 2,82% | 881.650 |
| 13/03/2019 | 71,30 | 73,31 | 70,19 | 72,56 | +2,61% | 4,37% | 931.984 |
| 12/03/2019 | 69,95 | 70,97 | 68,39 | 70,71 | +2,14% | 3,68% | 723.915 |
| 11/03/2019 | 66,39 | 69,25 | 65,96 | 69,23 | +4,77% | 4,95% | 911.947 |
| 08/03/2019 | 65,73 | 66,84 | 65,18 | 66,08 | -0,44% | 2,53% | 1.661.029 |
| 07/03/2019 | 66,30 | 66,99 | 65,27 | 66,38 | -0,11% | 2,59% | 1.454.081 |
| 06/03/2019 | 73,39 | 73,77 | 65,05 | 66,45 | -11,68% | 11,87% | 5.771.281 |
| 05/03/2019 | 76,73 | 76,73 | 75,18 | 75,24 | -1,70% | 2,02% | 428.482 |
| 04/03/2019 | 79,37 | 79,46 | 74,97 | 76,54 | -2,89% | 5,66% | 576.759 |
| 01/03/2019 | 78,13 | 79,26 | 77,47 | 78,81 | +1,82% | 2,29% | 540.371 |
| 28/02/2019 | 79,03 | 80,55 | 77,27 | 77,40 | -2,10% | 4,14% | 859.849 |
| 27/02/2019 | 76,96 | 80,07 | 76,70 | 79,06 | +2,35% | 4,39% | 718.946 |
| 26/02/2019 | 76,53 | 78,42 | 75,88 | 77,25 | +0,26% | 3,31% | 982.158 |
| 25/02/2019 | 75,47 | 77,63 | 74,87 | 77,05 | +3,46% | 3,65% | 798.615 |
| 22/02/2019 | 73,41 | 74,62 | 72,36 | 74,47 | +1,88% | 3,07% | 536.043 |
| 21/02/2019 | 74,12 | 74,83 | 72,43 | 73,10 | -1,45% | 3,24% | 524.662 |
| 20/02/2019 | 73,93 | 75,19 | 73,16 | 74,18 | +0,13% | 2,75% | 639.276 |
| 19/02/2019 | 75,40 | 75,66 | 73,54 | 74,08 | -1,75% | 2,82% | 720.549 |
| 15/02/2019 | 75,81 | 76,63 | 74,93 | 75,40 | -0,02% | 2,24% | 742.830 |
| 14/02/2019 | 75,02 | 76,11 | 74,37 | 75,41 | +0,37% | 2,32% | 550.951 |
| 13/02/2019 | 75,25 | 75,75 | 74,06 | 75,13 | +0,57% | 2,25% | 492.602 |
| 12/02/2019 | 73,92 | 74,78 | 72,94 | 74,71 | +1,52% | 2,49% | 769.761 |
| 11/02/2019 | 71,80 | 74,36 | 69,75 | 73,59 | +3,05% | 6,42% | 1.111.200 |
| 08/02/2019 | 74,86 | 75,39 | 70,63 | 71,42 | -1,75% | 6,36% | 2.210.056 |
| 07/02/2019 | 73,31 | 75,20 | 71,12 | 72,69 | -0,95% | 5,57% | 1.195.197 |
| 06/02/2019 | 72,81 | 74,71 | 72,81 | 73,39 | +0,61% | 2,61% | 525.624 |